Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» molnupiravir
molnupiravir
8 lingering questions about the new Covid pills from Merck and Pfizer
Stat
Mon, 11/15/21 - 10:38 am
COVID-19
antivirals
Merck
Pfizer
molnupiravir
Paxlovid
Merck's COVID-19 antiviral pill vs. Pfizer's: What's the same, what's different
Beckers Hospital Review
Sat, 11/13/21 - 09:51 pm
Merck
Pfizer
antivirals
COVID-19
molnupiravir
Paxlovid
Merck inks yet another $1B-plus supply deal for COVID pill, this time with Japan
Fierce Pharma
Wed, 11/10/21 - 09:32 pm
Merck
COVID-19
molnupiravir
Japan
US pays $1B to nearly double supply of Merck's COVID-19 pill
BioPharma Dive
Tue, 11/9/21 - 10:54 am
Merck
COVID-19
antivirals
molnupiravir
government contracts
Merck’s Covid-19 antiviral pill receives first authorization in U.K.
Stat
Thu, 11/4/21 - 10:47 am
Merck
COVID-19
molnupiravir
antivirals
UK
Merck’s Molnupiravir: When a Private-Public Partnership Bears Fruit
BioSpace
Wed, 11/3/21 - 11:33 pm
Merck
Ridgeback Biotherapeutics
molnupiravir
COVID-19
Emory
Go or go go? J&J’s cell therapy heads to the FDA
EP Vantage
Fri, 10/29/21 - 10:33 am
JNJ
cilta-cel
Multiple Myeloma
FDA
Biomarin
Merck
molnupiravir
Merck sees up to $7B in coming sales of coronavirus pill
BioPharma Dive
Thu, 10/28/21 - 10:21 pm
Merck
COVID-19
antivirals
earnings
molnupiravir
Merck Inks Deal To Share Antiviral Covid Pill With Poorer Countries
Forbes
Wed, 10/27/21 - 10:59 am
Merck
antivirals
COVID-19
molnupiravir
EMA starts rolling review of Merck's molnupiravir, continuing rapid regulatory response to COVID-19 antiviral data
Fierce Biotech
Mon, 10/25/21 - 10:58 am
Merck
molnupiravir
antivirals
COVID-19
Ridgeback Biotherapeutics
EMA
Will Merck's COVID-19 Pill Sink Regeneron's and Eli Lilly's Antibody Therapy Sales?
Motley Fool
Fri, 10/22/21 - 12:18 pm
Merck
COVID-19
molnupiravir
Regeneron
Eli Lilly
antibodies
Gates Foundation will provide $120 million to ensure generic production of Merck’s Covid-19 pill
Stat
Wed, 10/20/21 - 10:07 am
Gates Foundation
generics
COVID-19
antivirals
Merck
molnupiravir
Merck’s Covid-19 Pill Set for Review by FDA Advisory Panel
Bloomberg
Fri, 10/15/21 - 11:08 am
Merck
FDA
antivirals
COVID-19
molnupiravir
Merck’s breakthrough COVID pill faces a risk: the virus could outsmart it
Fortune
Tue, 10/12/21 - 11:02 am
Merck
COVID-19
molnupiravir
viral resistance
antivirals
Merck Reportedly Plans To Double Production Of New Covid-Fighting Pill As Wealthy Countries Corner Scarce Supplies
Forbes
Tue, 10/12/21 - 10:57 am
Merck
COVID-19
drug manufacturing
antivirals
molnupiravir
Merck asks FDA to authorize promising anti-COVID pill
NPR
Mon, 10/11/21 - 10:29 am
Merck
FDA
Ridgeback Therapeutics
COVID-19
antivirals
molnupiravir
Could a New COVID Pill Crush Vaccine Sales?
Motley Fool
Tue, 10/5/21 - 10:45 am
Merck
COVID-19
vaccines
molnupiravir
Ridgeback Biotherapeutics
Merck says research shows its COVID-19 pill works against variants
Reuters
Thu, 09/30/21 - 11:13 pm
Merck
antivirals
molnupiravir
COVID-19
Delta COVID-19 variant
Merck kicks off oral COVID-19 antiviral filing in Canada
Pharmaforum
Mon, 08/16/21 - 11:04 am
Merck
COVID-19
antivirals
Canada
Health Canada
molnupiravir
This Biopharma Giant May Have Just Found Its Ticket To Riches In the COVID-19 Market
Motley Fool
Thu, 06/17/21 - 10:50 am
Merck
Ridgeback Biotherapeutics
COVID-19
molnupiravir
antivirals
Pages
« first
‹ previous
1
2
3
next ›
last »